Forecast: Import of Heparin for Therapeutic Use to Japan

The forecast for Japan's imports of heparin for therapeutic use from 2024 to 2028 indicates a gradual year-on-year increase in value from $121.17 million to $131.97 million. For context, in 2023 the value stood at approximately $118.74 million. The growth reflects a consistent and moderate rise in demand, with a compound annual growth rate (CAGR) of around 2.1% over this five-year period. These trends highlight steady import growth, likely underpinned by increased therapeutic needs or healthcare demands.

Future trends to watch for include advancements in pharmaceutical manufacturing within Japan, shifts in healthcare policy affecting drug imports, and global supply chain dynamics that may influence import costs and availability. Monitoring regulatory changes and technological developments will also be critical in forecasting future demand for heparin imports.